These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1647 related items for PubMed ID: 31005243

  • 1. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
    Taxbro K, Hammarskjöld F, Thelin B, Lewin F, Hagman H, Hanberger H, Berg S.
    Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
    [Abstract] [Full Text] [Related]

  • 2. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
    Moss JG, Wu O, Bodenham AR, Agarwal R, Menne TF, Jones BL, Heggie R, Hill S, Dixon-Hughes J, Soulis E, Germeni E, Dillon S, McCartney E, CAVA trial group.
    Lancet; 2021 Jul 31; 398(10298):403-415. PubMed ID: 34297997
    [Abstract] [Full Text] [Related]

  • 3. Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.
    Wu O, McCartney E, Heggie R, Germeni E, Paul J, Soulis E, Dillon S, Ryan C, Sim M, Dixon-Hughes J, Agarwal R, Bodenham A, Menne T, Jones B, Moss J.
    Health Technol Assess; 2021 Jul 31; 25(47):1-126. PubMed ID: 34318743
    [Abstract] [Full Text] [Related]

  • 4. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies.
    Patel GS, Jain K, Kumar R, Strickland AH, Pellegrini L, Slavotinek J, Eaton M, McLeay W, Price T, Ly M, Ullah S, Koczwara B, Kichenadasse G, Karapetis CS.
    Support Care Cancer; 2014 Jan 31; 22(1):121-8. PubMed ID: 24005884
    [Abstract] [Full Text] [Related]

  • 5. Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days.
    Kang J, Chen W, Sun W, Ge R, Li H, Ma E, Su Q, Cheng F, Hong J, Zhang Y, Lei C, Wang X, Jin A, Liu W.
    J Vasc Access; 2017 Mar 21; 18(2):153-157. PubMed ID: 28218366
    [Abstract] [Full Text] [Related]

  • 6. Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failures.
    Bertoglio S, Faccini B, Lalli L, Cafiero F, Bruzzi P.
    J Surg Oncol; 2016 May 21; 113(6):708-14. PubMed ID: 27020965
    [Abstract] [Full Text] [Related]

  • 7. A comparison of infections and complications in central venous catheters in adults with solid tumours.
    Coady K, Ali M, Sidloff D, Kenningham RR, Ahmed S.
    J Vasc Access; 2015 May 21; 16(1):38-41. PubMed ID: 25198809
    [Abstract] [Full Text] [Related]

  • 8. A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison.
    Picardi M, Della Pepa R, Cerchione C, Pugliese N, Mortaruolo C, Trastulli F, Giordano C, Grimaldi F, Zacheo I, Raimondo M, Chiurazzi F, Pane F.
    Clin Lymphoma Myeloma Leuk; 2019 Apr 21; 19(4):e184-e194. PubMed ID: 30704933
    [Abstract] [Full Text] [Related]

  • 9. Patterns of use and outcomes of peripherally inserted central catheters in hospitalized patients with solid tumors: A multicenter study.
    Mitbander UB, Geer MJ, Taxbro K, Horowitz JK, Zhang Q, O'Malley ME, Ramnath N, Chopra V.
    Cancer; 2022 Oct 21; 128(20):3681-3690. PubMed ID: 35943390
    [Abstract] [Full Text] [Related]

  • 10. Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.
    Clatot F, Fontanilles M, Lefebvre L, Lequesne J, Veyret C, Alexandru C, Leheurteur M, Guillemet C, Gouérant S, Petrau C, Théry JC, Rigal O, Moldovan C, Tennevet I, Rastelli O, Poullain A, Savary L, Bubenheim M, Georgescu D, Gouérant J, Gilles-Baray M, Di Fiore F.
    Eur J Cancer; 2020 Feb 21; 126():116-124. PubMed ID: 31931269
    [Abstract] [Full Text] [Related]

  • 11. Peripherally inserted central catheters in the treatment of children with cancer: Results of a multicenter study.
    Rykov MY, Zaborovskij SV, Shvecov AN, Shukin VV.
    J Vasc Access; 2018 Jul 21; 19(4):378-381. PubMed ID: 29546772
    [Abstract] [Full Text] [Related]

  • 12. Complications of implanted port catheters and peripherally inserted central catheters in chemotherapy-treated cancer patients: A meta-analysis.
    Sun Y, Wu X.
    Adv Clin Exp Med; 2023 May 21; 32(5):523-532. PubMed ID: 36530028
    [Abstract] [Full Text] [Related]

  • 13. Peripherally inserted central catheters inserted with current best practices have low deep vein thrombosis and central line-associated bloodstream infection risk compared with centrally inserted central catheters: A contemporary meta-analysis.
    Schears GJ, Ferko N, Syed I, Arpino JM, Alsbrooks K.
    J Vasc Access; 2021 Jan 21; 22(1):9-25. PubMed ID: 32356479
    [Abstract] [Full Text] [Related]

  • 14. Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children.
    Menéndez JJ, Verdú C, Calderón B, Gómez-Zamora A, Schüffelmann C, de la Cruz JJ, de la Oliva P.
    J Thromb Haemost; 2016 Nov 21; 14(11):2158-2168. PubMed ID: 27558946
    [Abstract] [Full Text] [Related]

  • 15. A Randomized Trial of Central Venous Catheter Type and Thrombosis in Critically Ill Neurologic Patients.
    Fletcher JJ, Wilson TJ, Rajajee V, Stetler WR, Jacobs TL, Sheehan KM, Brown DL.
    Neurocrit Care; 2016 Aug 21; 25(1):20-8. PubMed ID: 26842716
    [Abstract] [Full Text] [Related]

  • 16. Cost analysis comparison between peripherally inserted central catheters and implanted chest ports in patients with cancer-A health economic evaluation of the PICCPORT trial.
    Taxbro K, Hammarskjöld F, Juhlin D, Hagman H, Bernfort L, Berg S.
    Acta Anaesthesiol Scand; 2020 Mar 21; 64(3):385-393. PubMed ID: 31721153
    [Abstract] [Full Text] [Related]

  • 17. Patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy.
    Chen Y, Chen H, Yang J, Jin W, Fu D, Liu M, Xu Y, Tao Z, Li Y, Lu L, Wang M, Zhu C, Chen Y.
    J Vasc Surg Venous Lymphat Disord; 2020 Nov 21; 8(6):919-929. PubMed ID: 32205131
    [Abstract] [Full Text] [Related]

  • 18. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
    Chan RJ, Northfield S, Larsen E, Mihala G, Ullman A, Hancock P, Marsh N, Gavin N, Wyld D, Allworth A, Russell E, Choudhury MA, Flynn J, Rickard CM.
    Trials; 2017 Oct 04; 18(1):458. PubMed ID: 28978332
    [Abstract] [Full Text] [Related]

  • 19. Comparison of outcomes of central venous catheters in patients with solid and hematologic neoplasms: an Italian real-world analysis.
    Corti F, Brambilla M, Manglaviti S, Di Vico L, Pisanu MN, Facchinetti C, Dotti KF, Lanocita R, Marchianò A, de Braud F, Ferrari LAM.
    Tumori; 2021 Feb 04; 107(1):17-25. PubMed ID: 32529962
    [Abstract] [Full Text] [Related]

  • 20. Azygos vein thrombosis secondary to a peripherally inserted central catheter (PICC).
    Sherif MM, Hall R, Schauer CK.
    J Vasc Access; 2015 Jul 20; 16(4):e82-3. PubMed ID: 25953208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 83.